Insider · CIK 0001742152
Samuel Rubinstein
Files at SSKN (STRATA Skin Sciences, Inc.), MDWD (MediWound Ltd.). First filing Nov 18, 2025, latest Sep 2, 2026.
In brief
Samuel Rubinstein files SEC Form 4 as director at MDWD (MediWound Ltd.), and also at SSKN (STRATA Skin Sciences, Inc.). Since Nov 18, 2025, Samuel Rubinstein has reported 3 open-market buys worth $16k and 2 open-market sells worth $25k, the latest filed on Sep 2, 2026.
A track record needs three past buys with six months of prices behind them; Samuel Rubinstein has 1, so none is measured yet.
The newest scored trade: bought $6,626 of MDWD on Sep 1, 2026, filed Sep 2, 2026, scored 23 (weak). In the last 12 months: 3 buys worth $16k and 2 sells worth $25k.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
MDWD: MediWound Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
SSKN: STRATA Skin Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | MDWDbuy MediWound Ltd. | $6,626 525 shares | - | - | |
| 43Moderate | MediWound Ltd. | $6,678 525 shares | -100% | +0% from low-36% from high | |
| 51Moderate | MediWound Ltd. | $2,150 150 shares | +5% | 0% from low-36% from high | |
| 25Weak | SSKNbuy STRATA Skin Sciences, Inc. | $7,028 5,000 shares | +133% | - | |
| 35Weak | SSKNsell STRATA Skin Sciences, Inc. | $19k 14,094 shares | -79% | - |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | MDWD MediWound Ltd. | SOpen-market sale Ordinary Sharesindirect: By spouse | -525 | $12.72 | $6,678 | 0 | 41 d ago |
| Sep 1, 2026 | MDWD MediWound Ltd. | POpen-market purchase Ordinary Sharesindirect: By spouse | +525 | $12.62 | $6,626 | 525 | 41 d ago |
| May 29, 2026 | MDWD MediWound Ltd. | POpen-market purchase Ordinary Shares | +150 | $14.33 | $2,150 | 2,993 | Jun 1, 2026 |
| Nov 17, 2025 | SSKN STRATA Skin Sciences, Inc. | SOpen-market sale Common Stock | -5,500 | $1.32 | $7,260 | 12,360 | Nov 18, 2025 |
| Nov 17, 2025 | SSKN STRATA Skin Sciences, Inc. | SOpen-market sale Common Stock | -7,200 | $1.34 | $9,648 | 5,160 | Nov 18, 2025 |
| Nov 17, 2025 | SSKN STRATA Skin Sciences, Inc. | SOpen-market sale Common Stock | -1,394 | $1.36 | $1,896 | 3,766 | Nov 18, 2025 |
| Nov 18, 2025 | SSKN STRATA Skin Sciences, Inc. | POpen-market purchase Common Stock | +2,168 | $1.40 | $3,035 | 5,934 | Nov 18, 2025 |
| Nov 18, 2025 | SSKN STRATA Skin Sciences, Inc. | POpen-market purchase Common Stock | +2,832 | $1.41 | $3,993 | 8,766 | Nov 18, 2025 |
Questions about Samuel Rubinstein
Answered from the filings on this page, as of the latest one.
Is Samuel Rubinstein buying or selling?
In the last 12 months Samuel Rubinstein reported 3 open-market buys worth $16k and 2 open-market sells worth $25k on SEC Form 4; the latest was bought $6,626 of MDWD on Sep 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Samuel Rubinstein's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Samuel Rubinstein has 1.
Where does Samuel Rubinstein file Form 4?
Samuel Rubinstein has filed Form 4 at MDWD (MediWound Ltd.); SSKN (STRATA Skin Sciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.